Lupin gets USFDA nod for Empagliflozin, Metformin Hydrochloride ER Tablets Ruchika Sharma8 Jan 2021 11:19 AM ISTMumbai, Baltimore: Drugmaker, Lupin Limited, has recently announced that the company has received tentative approval for its Empagliflozin and...
Empagliflozin can treat and reverse heart failure in non-diabetic patients also: Study Dr. Kamal Kant Kohli16 Nov 2020 10:30 AM ISTResearchers at the Icahn School of Medicine at Mount Sinai have found in a new trial known as EMPATROPISM, that diabetes drug Empagliflozin can...
Empagliflozin plus loop diuretics significantly increase urine volume in diabetes with HF Medha Baranwal10 Nov 2020 10:15 AM ISTUK: The use of SGLT2 inhibitor empagliflozin in combination with loop diuretics in patients with type 2 diabetes (T2D) and heart failure, helps in...
Empagliflozin may reduce hospitalization and death risk in heart failure: Study Dr Satabdi Saha26 Oct 2020 8:00 AM ISTAccording to a recent research, patients receiving empagliflozin therapy for heart failure, showed a lower risk of cardiovascular death or...
Empagliflozin lowers death risk in HF in non Diabetics also: NEJM Medha Baranwal17 Oct 2020 10:30 AM ISTUSA: The use of SGLT2 inhibitor empagliflozin in heart failure patients lowers the risk of cardiovascular death and hospitalization for...
Empagliflozin and linagliptin combo effective in Indian type 2 diabetes patients: JAPI Medha Baranwal13 Oct 2020 6:00 PM ISTIndia: A recent study based on real-world evidence from the Indian population (having type 2 diabetes) has shown the effectiveness of...
SGLT2 inhibitors improve survival and renal outcomes in heart failure: Lancet Medha Baranwal16 Sept 2020 7:50 AM ISTFrance: Treatment with empagliflozin and dapagliflozin reduces all-cause mortality and improves renal outcomes in patients with heart failure with...
Zydus Cadila generic empagliflozin, linagliptin tablets get tentative USFDA nod Medical Dialogues Bureau10 Sept 2020 2:27 PM ISTZydus Cadila Ltd's medication contains a combination of Empagliflozin and Linagliptin, oral diabetes medicines that help control blood sugar levels.
ESC update: Empagliflozin Cuts risk of Hospitalization, CV Mortality in HFrEF: EMPEROR Hina Zahid29 Aug 2020 11:45 AM ISTSophia Antipolis, France - Empagliflozin is second SGLT2 inhibitor after dapagliflozin to show a significant benefit in the treatment of reduced...
Empagliflozin add on to insulin premix effectively lowers blood sugar in diabetes: Study Medha Baranwal25 Aug 2020 7:09 PM ISTTaiwan: The addition of SGLT2 inhibitor empagliflozin versus linagliptin for 24 weeks to premixed insulin provides better blood sugar...
Diabetes Management: Alembic Pharma gets tentative USFDA nod to Empagliflozin, Metformin Hydrochloride tablets Farhat Nasim20 July 2020 2:13 PM ISTThe tentatively approved Empagliflozin and Metformin Hydrochloride tablets are therapeutically equivalent to Synjardy tablets of Boehringer Ingelheim...
ADA 2020: Empagliflozin reduces insulin need in diabetes patients Medha Baranwal17 Jun 2020 8:36 PM ISTDelhi: Treatment with the SGLT2 inhibitor empagliflozin reduces dependency on insulin in patients with type 2 diabetes (T2D) and cardiovascular...
